Hepatology
Volume 74, Issue 3 pp. 1708-1709
Correspondence

Letter to the Editor: Examining HBV-RNA Kinetics During NA Treatment—Are NAs Multifunctional Antiviral Agents?

Harel Dahari Ph.D., 

Harel Dahari Ph.D.

The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL

Search for more papers by this author
Andrew Vaillant Ph.D., 

Andrew Vaillant Ph.D.

Replicor Inc., Montreal, Quebec, Canada

Search for more papers by this author
Scott J. Cotler M.D., 

Scott J. Cotler M.D.

The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL

Search for more papers by this author
First published: 13 November 2020
https://doi.org/10.1002/hep.31627
Potential conflict of interest: Dr. Vaillant is employed and owns stock in Replicor. Supported by the U.S. National Institutes of Health Grant Nos. R01-AI144112 and R01-AI146917.
No abstract is available for this article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.